Awards

Call us Now

+41 44 741 8181

Call Back

Request Here

Make Appointment

Come to us @ ELZA

Email Us

info@elza-institute.com

Recommend Us

Thank you!

Telemedicine

Online consultation

  • Nikki Hafezi, Podium Power
Nikki Hafezi Challenges the Rare Disease Status of Keratoconus
Hafezi addressed the widespread reliance on a 1986 prevalence estimate that places keratoconus at 1 in 2,000—formally classifying it as rare. Yet as she highlighted, emerging epidemiological data tell a starkly different story. Keratoconus is an orphan disease, not a rare one.
  • by Mark Hillen
  • May 2, 2025
Read More
  • Awards, Farhad Hafezi, General, News, Podium Power, Popular press, Top 10
Prof. Farhad Hafezi: Power List 2025
Who is the best eye doctor in Zurich? In Switzerland? In the world? While such questions are inherently subjective, peer recognition provides a meaningful benchmark. Medical trade journal, The Ophthalmologist seeks to answer this by publishing its biennial Power List—a global selection of the 100 most influential individuals shaping the future of ophthalmology.
  • by Mark Hillen
  • April 7, 2025
Read More
Emilio-Torres-Netto-World-Cornea-Congress
  • Emilio Torres, Podium Power
Dr. Emilio Torres-Netto at WCC 2025
At the WCC 2025 congress in Washington, DC, Dr. Emilio A. Torres-Netto of the ELZA Institute presented groundbreaking research on ELZA-PACE-CXL, ELZA-sub400 CXL, and Femto-CAIRS, pushing the boundaries of keratoconus treatment.
  • by Mark Hillen
  • April 3, 2025
Read More
  • Farhad Hafezi, Podium Power, Popular press, Video Interview, Videos
ELZA-PACE in OSN at Winter ESCRS
ELZA-PACE combines epi-on cross-linking with customized PTK for keratoconus without stromal tissue removal – as reported by Ocular Surgery News
  • by Mark Hillen
  • April 2, 2025
Read More
Prof Farhad Hafezi on the podium - his view
  • Emilio Torres, Farhad Hafezi, Podium Power
ELZA at the ESCRS Winter Meeting 2025
At the ESCRS Winter Meeting 2025, Prof. Farhad Hafezi and Dr. Emilio Torres-Netto presented research on corneal cross-linking (CXL), including high-fluence protocols, keratoconus management, and biomechanical assessments.
  • by Mark Hillen
  • March 4, 2025
Read More
  • Nikki Hafezi, Podium Power, Video Interview
Swiss Days 2024: ELZA’s Impact in Uzbekistan
During Swiss Days 2024 in Tashkent, the ELZA Institute’s CEO, Nikki L. Hafezi, led a keratoconus screening initiative that identified critical cases and strengthened Swiss-Uzbek collaborations. The event, featured on Zo’r TV, highlights ELZA’s global healthcare impact.
  • by Mark Hillen
  • December 5, 2024
Read More
  • Farhad Hafezi, Nikki Hafezi, Podium Power
ELZA Takes Center Stage at CAU
Central Asian University (CAU) recently hosted a highly anticipated guest lecture on “Enterprising Ophthalmology,” featuring ELZA’s CEO and CMO, Nikki and Farhad Hafezi.
  • by Mark Hillen
  • November 14, 2024
Read More
PREV12345Next
.
.